fanta.bio Sample: CNhs11866
20485 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| SCML2 SRX644728 | 293 Kidney | 1907 / 18550 (10.3%) | 649 / 185500 (0.3%) | −324.0 | −324.0 | 29.38 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 562 / 18550 (3.0%) | 193 / 185500 (0.1%) | −324.0 | −324.0 | 29.12 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2037 / 18550 (11.0%) | 731 / 185500 (0.4%) | −324.0 | −324.0 | 27.87 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2822 / 18550 (15.2%) | 1132 / 185500 (0.6%) | −324.0 | −324.0 | 24.93 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2729 / 18550 (14.7%) | 1123 / 185500 (0.6%) | −324.0 | −324.0 | 24.30 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1184 / 18550 (6.4%) | 491 / 185500 (0.3%) | −324.0 | −324.0 | 24.11 |
| FOXP1 SRX736067 | LNCAP Prostate | 2421 / 18550 (13.1%) | 1024 / 185500 (0.6%) | −324.0 | −324.0 | 23.64 |
| HIF1A SRX11007095 | HK-2 Kidney | 2263 / 18550 (12.2%) | 1034 / 185500 (0.6%) | −324.0 | −324.0 | 21.89 |
| HIF1A SRX20663235 | HK-2 Kidney | 549 / 18550 (3.0%) | 286 / 185500 (0.2%) | −324.0 | −324.0 | 19.20 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1661 / 18550 (9.0%) | 900 / 185500 (0.5%) | −324.0 | −324.0 | 18.46 |
| MYH11 SRX265221 | ME-1 Blood | 1077 / 18550 (5.8%) | 606 / 185500 (0.3%) | −324.0 | −324.0 | 17.77 |
| TP53 SRX19538279 | Osteoblasts Bone | 531 / 18550 (2.9%) | 320 / 185500 (0.2%) | −324.0 | −324.0 | 16.59 |
| MED1 SRX9419945 | BT-474 Breast | 3775 / 18550 (20.4%) | 3043 / 185500 (1.6%) | −324.0 | −324.0 | 12.41 |
| MED1 SRX9419944 | BT-474 Breast | 3680 / 18550 (19.8%) | 2980 / 185500 (1.6%) | −324.0 | −324.0 | 12.35 |
| MED1 SRX9419946 | BT-474 Breast | 3835 / 18550 (20.7%) | 3192 / 185500 (1.7%) | −324.0 | −324.0 | 12.01 |
| BRD4 SRX9419938 | BT-474 Breast | 3769 / 18550 (20.3%) | 3193 / 185500 (1.7%) | −324.0 | −324.0 | 11.80 |
| BRD4 SRX9419936 | BT-474 Breast | 3802 / 18550 (20.5%) | 3221 / 185500 (1.7%) | −324.0 | −324.0 | 11.80 |
| BRD4 SRX9419935 | BT-474 Breast | 3617 / 18550 (19.5%) | 3074 / 185500 (1.7%) | −324.0 | −324.0 | 11.77 |
| BRD4 SRX9419937 | BT-474 Breast | 3632 / 18550 (19.6%) | 3099 / 185500 (1.7%) | −324.0 | −324.0 | 11.72 |
| MED1 SRX9419947 | BT-474 Breast | 3676 / 18550 (19.8%) | 3157 / 185500 (1.7%) | −324.0 | −324.0 | 11.64 |
| EZH2 SRX2146136 | LNCAP Prostate | 9163 / 18550 (49.4%) | 8400 / 185500 (4.5%) | −324.0 | −324.0 | 10.91 |
| BRD4 SRX736201 | 90-8TL Neural | 6399 / 18550 (34.5%) | 7266 / 185500 (3.9%) | −324.0 | −324.0 | 8.81 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2037 / 18550 (11.0%) | 2879 / 185500 (1.6%) | −324.0 | −324.0 | 7.08 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 946 / 18550 (5.1%) | 26639 / 185500 (14.4%) | −324.0 | −324.0 | 0.36 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 920 / 18550 (5.0%) | 26893 / 185500 (14.5%) | −324.0 | −324.0 | 0.34 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 588 / 18550 (3.2%) | 20744 / 185500 (11.2%) | −324.0 | −324.0 | 0.28 |
| PBX4 SRX2731658 | PC-3 Prostate | 786 / 18550 (4.2%) | 29443 / 185500 (15.9%) | −324.0 | −324.0 | 0.27 |
| AR SRX1067071 | LHSAR Prostate | 496 / 18550 (2.7%) | 19193 / 185500 (10.3%) | −324.0 | −324.0 | 0.26 |
| JUNB SRX8488088 | SUM 229PE Breast | 480 / 18550 (2.6%) | 19035 / 185500 (10.3%) | −324.0 | −324.0 | 0.25 |
| FOS SRX150478 | MCF 10A Breast | 512 / 18550 (2.8%) | 22452 / 185500 (12.1%) | −324.0 | −324.0 | 0.23 |
| FOS SRX150517 | MCF 10A Breast | 397 / 18550 (2.1%) | 17742 / 185500 (9.6%) | −324.0 | −324.0 | 0.22 |
| FOS SRX150477 | MCF 10A Breast | 465 / 18550 (2.5%) | 21912 / 185500 (11.8%) | −324.0 | −324.0 | 0.21 |
| YAP1 SRX757325 | H2052 Lung | 475 / 18550 (2.6%) | 22811 / 185500 (12.3%) | −324.0 | −324.0 | 0.21 |
| FOS SRX4192880 | MCF 10A Breast | 351 / 18550 (1.9%) | 17857 / 185500 (9.6%) | −324.0 | −324.0 | 0.20 |
| YAP1 SRX757326 | H2052 Lung | 396 / 18550 (2.1%) | 20457 / 185500 (11.0%) | −324.0 | −324.0 | 0.19 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 645 / 18550 (3.5%) | 21507 / 185500 (11.6%) | −323.0 | −320.0 | 0.30 |
| AR SRX1067070 | LHSAR Prostate | 674 / 18550 (3.6%) | 21936 / 185500 (11.8%) | −321.7 | −318.8 | 0.31 |
| JUNB SRX8488073 | SUM 229PE Breast | 475 / 18550 (2.6%) | 18550 / 185500 (10.0%) | −320.8 | −317.8 | 0.26 |
| AR SRX10820653 | LNCAP Prostate | 453 / 18550 (2.4%) | 182 / 185500 (0.1%) | −317.5 | −314.6 | 24.89 |
| FOS SRX150476 | MCF 10A Breast | 445 / 18550 (2.4%) | 17851 / 185500 (9.6%) | −315.0 | −312.1 | 0.25 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 945 / 18550 (5.1%) | 25851 / 185500 (13.9%) | −311.8 | −308.9 | 0.37 |
| KAT7 SRX101303 | RKO Digestive tract | 1714 / 18550 (9.2%) | 5556 / 185500 (3.0%) | −307.4 | −304.5 | 3.08 |
| SS18 SRX3468047 | Fibroblasts Others | 722 / 18550 (3.9%) | 22215 / 185500 (12.0%) | −306.1 | −303.2 | 0.33 |
| Epitope tags SRX10549776 | K-562 Blood | 1727 / 18550 (9.3%) | 5652 / 185500 (3.0%) | −305.5 | −302.6 | 3.06 |
| GATA3 SRX190194 | SK-N-SH Neural | 677 / 18550 (3.6%) | 21418 / 185500 (11.5%) | −303.8 | −300.9 | 0.32 |
| JUN SRX17561461 | LPS141 Adipocyte | 366 / 18550 (2.0%) | 15948 / 185500 (8.6%) | −299.0 | −296.1 | 0.23 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 601 / 18550 (3.2%) | 19992 / 185500 (10.8%) | −297.8 | −295.0 | 0.30 |
| TP53 SRX19538274 | U2OS Bone | 441 / 18550 (2.4%) | 201 / 185500 (0.1%) | −297.6 | −294.8 | 21.94 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 738 / 18550 (4.0%) | 1023 / 185500 (0.6%) | −296.9 | −294.0 | 7.21 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1126 / 18550 (6.1%) | 27958 / 185500 (15.1%) | −295.5 | −292.7 | 0.40 |
| FOS SRX4192879 | MCF 10A Breast | 270 / 18550 (1.5%) | 13965 / 185500 (7.5%) | −293.6 | −290.8 | 0.19 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 874 / 18550 (4.7%) | 24090 / 185500 (13.0%) | −291.4 | −288.6 | 0.36 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1408 / 18550 (7.6%) | 4093 / 185500 (2.2%) | −289.7 | −286.9 | 3.44 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 229 / 18550 (1.2%) | 13022 / 185500 (7.0%) | −289.5 | −286.7 | 0.18 |
| TCF12 SRX190356 | SK-N-SH Neural | 831 / 18550 (4.5%) | 23342 / 185500 (12.6%) | −288.6 | −285.8 | 0.36 |
| BRD1 SRX286203 | RKO Digestive tract | 1474 / 18550 (7.9%) | 4474 / 185500 (2.4%) | −287.3 | −284.5 | 3.29 |
| SMARCA4 SRX5212366 | Mel270 Others | 341 / 18550 (1.8%) | 15122 / 185500 (8.2%) | −286.5 | −283.8 | 0.23 |
| SMARCA2 SRX8119677 | MeT-5A Others | 448 / 18550 (2.4%) | 16992 / 185500 (9.2%) | −284.6 | −281.8 | 0.26 |
| BRPF3 SRX796084 | RKO Digestive tract | 1854 / 18550 (10.0%) | 6703 / 185500 (3.6%) | −283.4 | −280.7 | 2.77 |
| AGO2 SRX4708039 | Hep G2 Liver | 2092 / 18550 (11.3%) | 8176 / 185500 (4.4%) | −282.8 | −280.0 | 2.56 |
| SMARCA4 SRX5212362 | Mel270 Others | 486 / 18550 (2.6%) | 17591 / 185500 (9.5%) | −282.7 | −279.9 | 0.28 |
| TP53 SRX19538268 | U2OS Bone | 425 / 18550 (2.3%) | 205 / 185500 (0.1%) | −281.7 | −278.9 | 20.73 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 565 / 18550 (3.0%) | 18810 / 185500 (10.1%) | −279.1 | −276.4 | 0.30 |
| JUNB SRX8488074 | SUM 229PE Breast | 347 / 18550 (1.9%) | 14989 / 185500 (8.1%) | −278.2 | −275.5 | 0.23 |
| ESR1 SRX371478 | MCF-7 Breast | 358 / 18550 (1.9%) | 15145 / 185500 (8.2%) | −276.6 | −273.9 | 0.24 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 343 / 18550 (1.8%) | 14871 / 185500 (8.0%) | −276.6 | −273.9 | 0.23 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1269 / 18550 (6.8%) | 29263 / 185500 (15.8%) | −275.3 | −272.6 | 0.43 |
| ESR1 SRX4367193 | MCF-7 Breast | 1044 / 18550 (5.6%) | 26003 / 185500 (14.0%) | −273.7 | −271.0 | 0.40 |
| BMI1 SRX644729 | 293 Kidney | 356 / 18550 (1.9%) | 100 / 185500 (0.1%) | −273.3 | −270.6 | 35.60 |
| ESR1 SRX7624157 | MCF-7 Breast | 827 / 18550 (4.5%) | 22745 / 185500 (12.3%) | −272.7 | −270.1 | 0.36 |
| JUN SRX883584 | MDA-MB-231 Breast | 446 / 18550 (2.4%) | 16591 / 185500 (8.9%) | −272.6 | −269.9 | 0.27 |
| TP53 SRX19538276 | U2OS Bone | 421 / 18550 (2.3%) | 219 / 185500 (0.1%) | −272.1 | −269.4 | 19.22 |
| SMARCA4 SRX5212357 | Mel270 Others | 397 / 18550 (2.1%) | 15701 / 185500 (8.5%) | −271.6 | −269.0 | 0.25 |
| JUNB SRX10119386 | MCF 10A Breast | 207 / 18550 (1.1%) | 12068 / 185500 (6.5%) | −271.2 | −268.6 | 0.17 |
| SMARCA4 SRX5212371 | Mel270 Others | 391 / 18550 (2.1%) | 15575 / 185500 (8.4%) | −271.0 | −268.4 | 0.25 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 580 / 18550 (3.1%) | 18795 / 185500 (10.1%) | −270.8 | −268.2 | 0.31 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 220 / 18550 (1.2%) | 12281 / 185500 (6.6%) | −269.3 | −266.7 | 0.18 |
| AR SRX10820651 | LNCAP Prostate | 460 / 18550 (2.5%) | 316 / 185500 (0.2%) | −267.8 | −265.2 | 14.56 |
| MEAF6 DRX234811 | 293 Kidney | 2053 / 18550 (11.1%) | 8198 / 185500 (4.4%) | −267.0 | −264.4 | 2.50 |
| TP53 SRX19538267 | U2OS Bone | 392 / 18550 (2.1%) | 177 / 185500 (0.1%) | −265.3 | −262.7 | 22.15 |
| JUNB SRX4192882 | MCF 10A Breast | 180 / 18550 (1.0%) | 11319 / 185500 (6.1%) | −264.7 | −262.1 | 0.16 |
| ESR1 SRX176860 | MCF-7 Breast | 502 / 18550 (2.7%) | 17301 / 185500 (9.3%) | −264.5 | −261.9 | 0.29 |
| MEAF6 DRX300417 | 293 Kidney | 1890 / 18550 (10.2%) | 7233 / 185500 (3.9%) | −263.4 | −260.8 | 2.61 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 402 / 18550 (2.2%) | 15526 / 185500 (8.4%) | −262.9 | −260.3 | 0.26 |
| JUN SRX6582171 | GM07492 Others | 594 / 18550 (3.2%) | 18760 / 185500 (10.1%) | −262.7 | −260.1 | 0.32 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 525 / 18550 (2.8%) | 17555 / 185500 (9.5%) | −260.4 | −257.8 | 0.30 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 259 / 18550 (1.4%) | 12806 / 185500 (6.9%) | −260.2 | −257.6 | 0.20 |
| FOXA1 SRX176862 | MCF-7 Breast | 398 / 18550 (2.1%) | 15371 / 185500 (8.3%) | −260.0 | −257.5 | 0.26 |
| NR3C1 SRX2609664 | HASM2 Lung | 399 / 18550 (2.2%) | 15388 / 185500 (8.3%) | −260.0 | −257.4 | 0.26 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 386 / 18550 (2.1%) | 15119 / 185500 (8.2%) | −258.8 | −256.3 | 0.26 |
| BRPF3 SRX796086 | RKO Digestive tract | 1737 / 18550 (9.4%) | 6376 / 185500 (3.4%) | −258.2 | −255.6 | 2.72 |
| TP53 SRX19538280 | Osteoblasts Bone | 413 / 18550 (2.2%) | 241 / 185500 (0.1%) | −256.2 | −253.7 | 17.14 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 535 / 18550 (2.9%) | 17586 / 185500 (9.5%) | −256.2 | −253.7 | 0.30 |
| JUN SRX6582172 | Fibroblasts Others | 378 / 18550 (2.0%) | 14897 / 185500 (8.0%) | −256.2 | −253.6 | 0.25 |
| FOSL2 SRX190296 | SK-N-SH Neural | 386 / 18550 (2.1%) | 15014 / 185500 (8.1%) | −255.3 | −252.8 | 0.26 |
| Epitope tags DRX443510 | 293 Kidney | 1783 / 18550 (9.6%) | 6719 / 185500 (3.6%) | −254.2 | −251.6 | 2.65 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 803 / 18550 (4.3%) | 21725 / 185500 (11.7%) | −253.5 | −251.0 | 0.37 |
| BRPF3 SRX796085 | RKO Digestive tract | 1299 / 18550 (7.0%) | 3928 / 185500 (2.1%) | −253.4 | −250.8 | 3.31 |
| MAU2 SRX15710550 | Fibroblasts Others | 502 / 18550 (2.7%) | 16943 / 185500 (9.1%) | −253.2 | −250.7 | 0.30 |
| JUN SRX4192884 | MCF 10A Breast | 212 / 18550 (1.1%) | 11654 / 185500 (6.3%) | −252.6 | −250.1 | 0.18 |
| JUNB SRX8488089 | SUM 229PE Breast | 272 / 18550 (1.5%) | 12826 / 185500 (6.9%) | −252.3 | −249.8 | 0.21 |
| FOXA1 SRX176863 | MCF-7 Breast | 373 / 18550 (2.0%) | 14659 / 185500 (7.9%) | −251.2 | −248.7 | 0.25 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 680 / 18550 (3.7%) | 1064 / 185500 (0.6%) | −250.9 | −248.4 | 6.39 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1159 / 18550 (6.2%) | 26746 / 185500 (14.4%) | −249.1 | −246.6 | 0.43 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 633 / 18550 (3.4%) | 18925 / 185500 (10.2%) | −248.6 | −246.1 | 0.33 |
| ESR1 SRX7624156 | MCF-7 Breast | 517 / 18550 (2.8%) | 17046 / 185500 (9.2%) | −248.6 | −246.1 | 0.30 |
| ESR1 SRX176861 | MCF-7 Breast | 529 / 18550 (2.9%) | 17233 / 185500 (9.3%) | −248.2 | −245.7 | 0.31 |
| ESR1 SRX20282961 | MCF-7 Breast | 392 / 18550 (2.1%) | 14894 / 185500 (8.0%) | −247.8 | −245.3 | 0.26 |
| ESR1 SRX371479 | MCF-7 Breast | 268 / 18550 (1.4%) | 12578 / 185500 (6.8%) | −246.3 | −243.8 | 0.21 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 360 / 18550 (1.9%) | 14272 / 185500 (7.7%) | −246.1 | −243.7 | 0.25 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 790 / 18550 (4.3%) | 21217 / 185500 (11.4%) | −244.6 | −242.1 | 0.37 |
| TP53 SRX19538273 | U2OS Bone | 374 / 18550 (2.0%) | 188 / 185500 (0.1%) | −244.5 | −242.0 | 19.89 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 369 / 18550 (2.0%) | 14376 / 185500 (7.7%) | −244.3 | −241.8 | 0.26 |
| NR3C1 SRX2609665 | HASM2 Lung | 317 / 18550 (1.7%) | 13432 / 185500 (7.2%) | −244.1 | −241.6 | 0.24 |
| EP300 SRX2671813 | Fibroblasts Others | 219 / 18550 (1.2%) | 11535 / 185500 (6.2%) | −243.4 | −240.9 | 0.19 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 567 / 18550 (3.1%) | 17664 / 185500 (9.5%) | −242.5 | −240.1 | 0.32 |
| JUND SRX190357 | SK-N-SH Neural | 383 / 18550 (2.1%) | 14536 / 185500 (7.8%) | −241.5 | −239.0 | 0.26 |
| NR3C1 SRX2609662 | HASM2 Lung | 355 / 18550 (1.9%) | 14037 / 185500 (7.6%) | −241.4 | −238.9 | 0.25 |
| TP53 SRX19538275 | U2OS Bone | 380 / 18550 (2.0%) | 208 / 185500 (0.1%) | −241.2 | −238.8 | 18.27 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 269 / 18550 (1.5%) | 12441 / 185500 (6.7%) | −241.0 | −238.6 | 0.22 |
| YAP1 SRX5718140 | 293 Kidney | 558 / 18550 (3.0%) | 17466 / 185500 (9.4%) | −240.9 | −238.4 | 0.32 |
| ESR1 SRX371469 | MCF-7 Breast | 324 / 18550 (1.7%) | 13464 / 185500 (7.3%) | −240.8 | −238.4 | 0.24 |
| PBX3 SRX190343 | SK-N-SH Neural | 696 / 18550 (3.8%) | 19644 / 185500 (10.6%) | −240.6 | −238.2 | 0.35 |
| TP53 SRX19538281 | Osteoblasts Bone | 440 / 18550 (2.4%) | 353 / 185500 (0.2%) | −239.4 | −237.0 | 12.46 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 327 / 18550 (1.8%) | 13435 / 185500 (7.2%) | −238.2 | −235.7 | 0.24 |
| JUNB SRX10119383 | MCF 10A Breast | 170 / 18550 (0.9%) | 10358 / 185500 (5.6%) | −237.4 | −235.0 | 0.16 |
| AR SRX1067067 | LHSAR Prostate | 557 / 18550 (3.0%) | 17307 / 185500 (9.3%) | −236.6 | −234.1 | 0.32 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 260 / 18550 (1.4%) | 12120 / 185500 (6.5%) | −235.9 | −233.5 | 0.21 |
| FOXA1 SRX4815197 | MCF-7 Breast | 855 / 18550 (4.6%) | 21857 / 185500 (11.8%) | −235.3 | −232.9 | 0.39 |
| VGLL1 SRX24602130 | BT-20 Breast | 319 / 18550 (1.7%) | 13199 / 185500 (7.1%) | −235.2 | −232.7 | 0.24 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 583 / 18550 (3.1%) | 17671 / 185500 (9.5%) | −234.9 | −232.5 | 0.33 |
| ESR1 SRX20282960 | MCF-7 Breast | 370 / 18550 (2.0%) | 14066 / 185500 (7.6%) | −233.6 | −231.2 | 0.26 |
| NR3C1 SRX2609659 | HASM2 Lung | 353 / 18550 (1.9%) | 13754 / 185500 (7.4%) | −233.1 | −230.7 | 0.26 |
| GATA3 SRX190239 | MCF-7 Breast | 498 / 18550 (2.7%) | 16220 / 185500 (8.7%) | −232.7 | −230.4 | 0.31 |
| STAT3 SRX150630 | MCF 10A Breast | 264 / 18550 (1.4%) | 12090 / 185500 (6.5%) | −232.2 | −229.9 | 0.22 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1028 / 18550 (5.5%) | 24232 / 185500 (13.1%) | −231.4 | −229.0 | 0.42 |
| NR3C1 SRX2609666 | HASM2 Lung | 280 / 18550 (1.5%) | 12366 / 185500 (6.7%) | −231.4 | −229.0 | 0.23 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 571 / 18550 (3.1%) | 17357 / 185500 (9.4%) | −231.3 | −228.9 | 0.33 |
| STAT3 SRX150479 | MCF 10A Breast | 269 / 18550 (1.5%) | 12149 / 185500 (6.5%) | −231.0 | −228.7 | 0.22 |
| EP300 SRX2194266 | SUM 159PT Breast | 578 / 18550 (3.1%) | 17459 / 185500 (9.4%) | −231.0 | −228.6 | 0.33 |
| FOS SRX070879 | HUVEC Cardiovascular | 321 / 18550 (1.7%) | 13090 / 185500 (7.1%) | −230.3 | −227.9 | 0.25 |
| CEBPB SRX150632 | HeLa Uterus | 789 / 18550 (4.3%) | 20672 / 185500 (11.1%) | −229.5 | −227.2 | 0.38 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 433 / 18550 (2.3%) | 15029 / 185500 (8.1%) | −229.5 | −227.1 | 0.29 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 497 / 18550 (2.7%) | 16096 / 185500 (8.7%) | −229.4 | −227.1 | 0.31 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 966 / 18550 (5.2%) | 2470 / 185500 (1.3%) | −229.1 | −226.8 | 3.91 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 434 / 18550 (2.3%) | 15028 / 185500 (8.1%) | −229.0 | −226.7 | 0.29 |
| NR3C1 SRX2609661 | HASM2 Lung | 342 / 18550 (1.8%) | 13415 / 185500 (7.2%) | −228.6 | −226.2 | 0.25 |
| EP300 SRX2194265 | SUM 159PT Breast | 517 / 18550 (2.8%) | 16397 / 185500 (8.8%) | −228.5 | −226.2 | 0.32 |
| BRD4 SRX736204 | 90-8TL Neural | 1081 / 18550 (5.8%) | 3073 / 185500 (1.7%) | −227.0 | −224.6 | 3.52 |
| FOXA1 SRX371481 | MCF-7 Breast | 353 / 18550 (1.9%) | 13546 / 185500 (7.3%) | −226.5 | −224.1 | 0.26 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 415 / 18550 (2.2%) | 14614 / 185500 (7.9%) | −226.1 | −223.8 | 0.28 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 499 / 18550 (2.7%) | 15994 / 185500 (8.6%) | −225.3 | −223.0 | 0.31 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 285 / 18550 (1.5%) | 12262 / 185500 (6.6%) | −224.6 | −222.3 | 0.23 |
| DAXX SRX1021630 | PC-3 Prostate | 306 / 18550 (1.6%) | 12643 / 185500 (6.8%) | −224.5 | −222.2 | 0.24 |
| FOXA1 SRX371482 | MCF-7 Breast | 507 / 18550 (2.7%) | 16096 / 185500 (8.7%) | −224.4 | −222.0 | 0.31 |
| EP300 SRX150579 | HeLa Uterus | 178 / 18550 (1.0%) | 10164 / 185500 (5.5%) | −224.4 | −222.0 | 0.18 |
| WWTR1 SRX10119367 | MCF 10A Breast | 378 / 18550 (2.0%) | 13920 / 185500 (7.5%) | −224.2 | −221.9 | 0.27 |
| YAP1 SRX10119364 | MCF 10A Breast | 248 / 18550 (1.3%) | 11533 / 185500 (6.2%) | −223.5 | −221.2 | 0.22 |
| ING5 SRX286202 | RKO Digestive tract | 1535 / 18550 (8.3%) | 5694 / 185500 (3.1%) | −222.9 | −220.6 | 2.70 |
| JUNB SRX10119384 | MCF 10A Breast | 160 / 18550 (0.9%) | 9713 / 185500 (5.2%) | −221.6 | −219.3 | 0.16 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 250 / 18550 (1.3%) | 11506 / 185500 (6.2%) | −221.3 | −219.0 | 0.22 |
| JUN SRX2355072 | HAEC Cardiovascular | 432 / 18550 (2.3%) | 14746 / 185500 (7.9%) | −221.2 | −218.8 | 0.29 |
| AR SRX1067066 | LHSAR Prostate | 752 / 18550 (4.1%) | 19814 / 185500 (10.7%) | −221.0 | −218.7 | 0.38 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 304 / 18550 (1.6%) | 12467 / 185500 (6.7%) | −219.9 | −217.6 | 0.24 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 308 / 18550 (1.7%) | 12540 / 185500 (6.8%) | −219.8 | −217.5 | 0.25 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 265 / 18550 (1.4%) | 11733 / 185500 (6.3%) | −219.4 | −217.1 | 0.23 |
| ESR1 SRX20282939 | MCF-7 Breast | 390 / 18550 (2.1%) | 13973 / 185500 (7.5%) | −219.3 | −217.0 | 0.28 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 512 / 18550 (2.8%) | 16004 / 185500 (8.6%) | −219.1 | −216.8 | 0.32 |
| FOS SRX150664 | HUVEC Cardiovascular | 440 / 18550 (2.4%) | 14803 / 185500 (8.0%) | −218.8 | −216.5 | 0.30 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 903 / 18550 (4.9%) | 21954 / 185500 (11.8%) | −218.6 | −216.3 | 0.41 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 443 / 18550 (2.4%) | 14842 / 185500 (8.0%) | −218.4 | −216.1 | 0.30 |
| JUN SRX7277180 | GM07492 Others | 248 / 18550 (1.3%) | 11379 / 185500 (6.1%) | −218.4 | −216.1 | 0.22 |
| GATA3 SRX176864 | MCF-7 Breast | 233 / 18550 (1.3%) | 11094 / 185500 (6.0%) | −218.4 | −216.1 | 0.21 |
| FOXA1 SRX371483 | MCF-7 Breast | 398 / 18550 (2.1%) | 14064 / 185500 (7.6%) | −217.8 | −215.5 | 0.28 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1525 / 18550 (8.2%) | 5718 / 185500 (3.1%) | −217.6 | −215.3 | 2.67 |
| JUND SRX150408 | HeLa Uterus | 272 / 18550 (1.5%) | 11804 / 185500 (6.4%) | −217.5 | −215.2 | 0.23 |
| TP53 SRX19538269 | U2OS Bone | 467 / 18550 (2.5%) | 509 / 185500 (0.3%) | −217.4 | −215.1 | 9.17 |
| ESR1 SRX20282954 | MCF-7 Breast | 369 / 18550 (2.0%) | 13544 / 185500 (7.3%) | −217.3 | −215.1 | 0.27 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 538 / 18550 (2.9%) | 16366 / 185500 (8.8%) | −217.3 | −215.1 | 0.33 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 282 / 18550 (1.5%) | 11987 / 185500 (6.5%) | −217.3 | −215.0 | 0.24 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 523 / 18550 (2.8%) | 16119 / 185500 (8.7%) | −217.2 | −214.9 | 0.32 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 203 / 18550 (1.1%) | 10423 / 185500 (5.6%) | −215.6 | −213.3 | 0.19 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 533 / 18550 (2.9%) | 731 / 185500 (0.4%) | −215.4 | −213.2 | 7.29 |
| JADE3 DRX300415 | 293 Kidney | 1770 / 18550 (9.5%) | 7298 / 185500 (3.9%) | −215.1 | −212.8 | 2.43 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 216 / 18550 (1.2%) | 10668 / 185500 (5.8%) | −215.1 | −212.8 | 0.20 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 822 / 18550 (4.4%) | 20636 / 185500 (11.1%) | −215.0 | −212.7 | 0.40 |
| ESR1 SRX371476 | MCF-7 Breast | 243 / 18550 (1.3%) | 11183 / 185500 (6.0%) | −214.9 | −212.7 | 0.22 |
| FOXA1 SRX1161177 | MCF-7 Breast | 356 / 18550 (1.9%) | 13237 / 185500 (7.1%) | −214.8 | −212.5 | 0.27 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 222 / 18550 (1.2%) | 10775 / 185500 (5.8%) | −214.8 | −212.5 | 0.21 |
| NFYB SRX16608147 | HeLa Uterus | 335 / 18550 (1.8%) | 179 / 185500 (0.1%) | −214.5 | −212.2 | 18.72 |
| TLE3 SRX4815191 | MCF-7 Breast | 335 / 18550 (1.8%) | 12840 / 185500 (6.9%) | −213.9 | −211.6 | 0.26 |
| FOXA1 SRX3931044 | MCF-7 Breast | 805 / 18550 (4.3%) | 20305 / 185500 (10.9%) | −212.7 | −210.5 | 0.40 |
| ESR1 SRX371467 | MCF-7 Breast | 365 / 18550 (2.0%) | 13328 / 185500 (7.2%) | −212.6 | −210.4 | 0.27 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 497 / 18550 (2.7%) | 15538 / 185500 (8.4%) | −212.5 | −210.3 | 0.32 |
| JUND SRX699738 | HCASMC Cardiovascular | 480 / 18550 (2.6%) | 15243 / 185500 (8.2%) | −211.9 | −209.6 | 0.31 |
| JUN SRX6582163 | BJ-5ta Epidermis | 425 / 18550 (2.3%) | 14332 / 185500 (7.7%) | −211.9 | −209.6 | 0.30 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 664 / 18550 (3.6%) | 18151 / 185500 (9.8%) | −211.8 | −209.5 | 0.37 |
| PRRX1 SRX15235713 | Hs 578T Breast | 413 / 18550 (2.2%) | 14121 / 185500 (7.6%) | −211.6 | −209.4 | 0.29 |
| ESR1 SRX20282972 | MCF-7 Breast | 389 / 18550 (2.1%) | 13686 / 185500 (7.4%) | −210.8 | −208.6 | 0.28 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 246 / 18550 (1.3%) | 11114 / 185500 (6.0%) | −210.6 | −208.4 | 0.22 |
| ESR1 SRX1531791 | MCF-7 Breast | 334 / 18550 (1.8%) | 12719 / 185500 (6.9%) | −210.5 | −208.3 | 0.26 |
| ESR1 SRX10365535 | MCF-7 Breast | 261 / 18550 (1.4%) | 11381 / 185500 (6.1%) | −210.2 | −208.0 | 0.23 |
| Epitope tags SRX10549778 | K-562 Blood | 1296 / 18550 (7.0%) | 4485 / 185500 (2.4%) | −208.9 | −206.7 | 2.89 |
| ESR1 SRX4367192 | MCF-7 Breast | 744 / 18550 (4.0%) | 19257 / 185500 (10.4%) | −208.8 | −206.6 | 0.39 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 462 / 18550 (2.5%) | 14833 / 185500 (8.0%) | −208.5 | −206.3 | 0.31 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 236 / 18550 (1.3%) | 10849 / 185500 (5.8%) | −208.1 | −205.9 | 0.22 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 599 / 18550 (3.2%) | 1014 / 185500 (0.5%) | −207.9 | −205.7 | 5.91 |
| STAT3 SRX150536 | MCF 10A Breast | 377 / 18550 (2.0%) | 13387 / 185500 (7.2%) | −207.9 | −205.7 | 0.28 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 633 / 18550 (3.4%) | 17520 / 185500 (9.4%) | −207.4 | −205.2 | 0.36 |
| ESR1 SRX194569 | MCF-7 Breast | 373 / 18550 (2.0%) | 13291 / 185500 (7.2%) | −207.0 | −204.8 | 0.28 |
| LEO1 SRX1873456 | SEM Blood | 1644 / 18550 (8.9%) | 6653 / 185500 (3.6%) | −205.9 | −203.7 | 2.47 |
| FOSL2 SRX190204 | A549 Lung | 327 / 18550 (1.8%) | 12452 / 185500 (6.7%) | −205.9 | −203.7 | 0.26 |
| FOXA1 SRX1161176 | MCF-7 Breast | 346 / 18550 (1.9%) | 12757 / 185500 (6.9%) | −205.0 | −202.8 | 0.27 |
| KAT7 DRX234808 | 293 Kidney | 931 / 18550 (5.0%) | 2546 / 185500 (1.4%) | −204.2 | −202.0 | 3.66 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 518 / 18550 (2.8%) | 15590 / 185500 (8.4%) | −203.8 | −201.6 | 0.33 |
| FOXA1 SRX1161173 | MCF-7 Breast | 283 / 18550 (1.5%) | 11569 / 185500 (6.2%) | −202.9 | −200.7 | 0.24 |
| JUN SRX6582165 | BJ-5ta Epidermis | 702 / 18550 (3.8%) | 18393 / 185500 (9.9%) | −202.3 | −200.1 | 0.38 |
| RAC1 SRX10365541 | MCF-7 Breast | 167 / 18550 (0.9%) | 9314 / 185500 (5.0%) | −202.3 | −200.1 | 0.18 |
| RAC1 SRX10365543 | MCF-7 Breast | 168 / 18550 (0.9%) | 9330 / 185500 (5.0%) | −202.0 | −199.8 | 0.18 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 323 / 18550 (1.7%) | 12258 / 185500 (6.6%) | −201.9 | −199.8 | 0.26 |
| ESR1 SRX10365536 | MCF-7 Breast | 168 / 18550 (0.9%) | 9325 / 185500 (5.0%) | −201.8 | −199.6 | 0.18 |
| FOXA1 SRX371480 | MCF-7 Breast | 235 / 18550 (1.3%) | 10621 / 185500 (5.7%) | −200.9 | −198.8 | 0.22 |
| NR3C1 SRX10976921 | A549 Lung | 222 / 18550 (1.2%) | 10362 / 185500 (5.6%) | −200.6 | −198.4 | 0.21 |
| TLE3 SRX4815194 | SUM 149PT Breast | 249 / 18550 (1.3%) | 10860 / 185500 (5.9%) | −200.2 | −198.1 | 0.23 |
| GATA3 SRX5057632 | MCF-7 Breast | 223 / 18550 (1.2%) | 10348 / 185500 (5.6%) | −199.6 | −197.4 | 0.22 |
| ESR1 SRX371471 | ZR-75-1 Breast | 407 / 18550 (2.2%) | 13628 / 185500 (7.3%) | −199.5 | −197.3 | 0.30 |
| RELA SRX5938177 | FaDu Others | 317 / 18550 (1.7%) | 12073 / 185500 (6.5%) | −199.4 | −197.3 | 0.26 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 602 / 18550 (3.2%) | 1081 / 185500 (0.6%) | −199.3 | −197.1 | 5.57 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 486 / 18550 (2.6%) | 14905 / 185500 (8.0%) | −198.8 | −196.6 | 0.33 |
| YAP1 SRX1038945 | IMR-90 Lung | 247 / 18550 (1.3%) | 10769 / 185500 (5.8%) | −198.4 | −196.2 | 0.23 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 206 / 18550 (1.1%) | 9972 / 185500 (5.4%) | −198.0 | −195.8 | 0.21 |
| WWTR1 SRX10119378 | MCF 10A Breast | 389 / 18550 (2.1%) | 13266 / 185500 (7.2%) | −197.7 | −195.5 | 0.29 |
| FOS SRX3322636 | MCF-7 Breast | 213 / 18550 (1.1%) | 10084 / 185500 (5.4%) | −197.1 | −195.0 | 0.21 |
| FOXA1 SRX1161175 | MCF-7 Breast | 271 / 18550 (1.5%) | 11149 / 185500 (6.0%) | −196.3 | −194.2 | 0.24 |
| ESR1 SRX371468 | MCF-7 Breast | 225 / 18550 (1.2%) | 10282 / 185500 (5.5%) | −196.0 | −193.8 | 0.22 |
| NKX2-1 SRX2164786 | A549 Lung | 616 / 18550 (3.3%) | 16832 / 185500 (9.1%) | −195.3 | −193.2 | 0.37 |
| ARID1A SRX5089376 | MCF-7 Breast | 310 / 18550 (1.7%) | 11816 / 185500 (6.4%) | −195.2 | −193.0 | 0.26 |
| ESR1 SRX20282973 | MCF-7 Breast | 443 / 18550 (2.4%) | 14066 / 185500 (7.6%) | −194.7 | −192.6 | 0.31 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 247 / 18550 (1.3%) | 10652 / 185500 (5.7%) | −194.4 | −192.3 | 0.23 |
| NR3C1 SRX10977357 | A549 Lung | 196 / 18550 (1.1%) | 9664 / 185500 (5.2%) | −194.0 | −191.9 | 0.20 |
| TP53 SRX19538270 | U2OS Bone | 433 / 18550 (2.3%) | 506 / 185500 (0.3%) | −193.5 | −191.4 | 8.56 |
| TP53 SRX19538282 | Osteoblasts Bone | 384 / 18550 (2.1%) | 362 / 185500 (0.2%) | −193.2 | −191.1 | 10.61 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 383 / 18550 (2.1%) | 13009 / 185500 (7.0%) | −193.0 | −190.8 | 0.29 |
| ESR1 SRX20282955 | MCF-7 Breast | 385 / 18550 (2.1%) | 13038 / 185500 (7.0%) | −192.8 | −190.6 | 0.30 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 366 / 18550 (2.0%) | 12712 / 185500 (6.9%) | −192.6 | −190.5 | 0.29 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 372 / 18550 (2.0%) | 12801 / 185500 (6.9%) | −192.3 | −190.2 | 0.29 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 528 / 18550 (2.8%) | 15338 / 185500 (8.3%) | −191.7 | −189.6 | 0.34 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 295 / 18550 (1.6%) | 11443 / 185500 (6.2%) | −191.7 | −189.6 | 0.26 |
| ESR1 SRX2881000 | MCF-7 Breast | 312 / 18550 (1.7%) | 11742 / 185500 (6.3%) | −191.7 | −189.6 | 0.27 |
| JUN SRX6582164 | BJ-5ta Epidermis | 465 / 18550 (2.5%) | 14307 / 185500 (7.7%) | −191.2 | −189.0 | 0.33 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1262 / 18550 (6.8%) | 4546 / 185500 (2.5%) | −190.9 | −188.8 | 2.78 |
| ESR1 SRX371470 | ZR-75-1 Breast | 351 / 18550 (1.9%) | 12391 / 185500 (6.7%) | −190.7 | −188.6 | 0.28 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 537 / 18550 (2.9%) | 15441 / 185500 (8.3%) | −190.6 | −188.5 | 0.35 |
| ESR1 SRX194572 | MCF-7 Breast | 231 / 18550 (1.2%) | 10217 / 185500 (5.5%) | −189.9 | −187.8 | 0.23 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1125 / 18550 (6.1%) | 23966 / 185500 (12.9%) | −189.8 | −187.7 | 0.47 |
| JUNB SRX10119385 | MCF 10A Breast | 135 / 18550 (0.7%) | 8297 / 185500 (4.5%) | −189.8 | −187.7 | 0.16 |
| EP300 SRX100540 | SK-N-SH Neural | 553 / 18550 (3.0%) | 15658 / 185500 (8.4%) | −189.7 | −187.6 | 0.35 |
| FOXA1 SRX100454 | T-47D Breast | 507 / 18550 (2.7%) | 14929 / 185500 (8.0%) | −189.6 | −187.5 | 0.34 |
| IRF3 SRX11453858 | Hep G2 Liver | 275 / 18550 (1.5%) | 117 / 185500 (0.1%) | −189.5 | −187.4 | 23.50 |
| EP300 ERX626811 | U-937 Blood | 1392 / 18550 (7.5%) | 5356 / 185500 (2.9%) | −189.5 | −187.4 | 2.60 |
| AGO2 SRX6783957 | Hep G2 Liver | 1329 / 18550 (7.2%) | 4973 / 185500 (2.7%) | −189.3 | −187.2 | 2.67 |
| WWTR1 SRX10119368 | MCF 10A Breast | 242 / 18550 (1.3%) | 10400 / 185500 (5.6%) | −189.2 | −187.1 | 0.23 |
| NR3C1 SRX17639412 | A549 Lung | 412 / 18550 (2.2%) | 13368 / 185500 (7.2%) | −189.1 | −187.0 | 0.31 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 215 / 18550 (1.2%) | 9883 / 185500 (5.3%) | −189.0 | −186.9 | 0.22 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 505 / 18550 (2.7%) | 774 / 185500 (0.4%) | −188.8 | −186.7 | 6.52 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 477 / 18550 (2.6%) | 14425 / 185500 (7.8%) | −188.8 | −186.7 | 0.33 |
| ESR1 SRX20282940 | MCF-7 Breast | 408 / 18550 (2.2%) | 13293 / 185500 (7.2%) | −188.7 | −186.6 | 0.31 |
| FOXL2 SRX6957431 | KGN Gonad | 891 / 18550 (4.8%) | 20647 / 185500 (11.1%) | −188.6 | −186.5 | 0.43 |
| FOXA1 SRX190181 | A549 Lung | 252 / 18550 (1.4%) | 10541 / 185500 (5.7%) | −187.7 | −185.6 | 0.24 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 993 / 18550 (5.4%) | 3059 / 185500 (1.6%) | −187.7 | −185.6 | 3.25 |
| STAT3 SRX2020842 | HCC70 Breast | 689 / 18550 (3.7%) | 17657 / 185500 (9.5%) | −187.4 | −185.3 | 0.39 |
| CDK9 SRX7366783 | MCF-7 Breast | 287 / 18550 (1.5%) | 145 / 185500 (0.1%) | −187.3 | −185.2 | 19.79 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 288 / 18550 (1.6%) | 11172 / 185500 (6.0%) | −187.0 | −184.9 | 0.26 |
| STAT5B SRX831881 | CD8+ T cells Blood | 291 / 18550 (1.6%) | 154 / 185500 (0.1%) | −187.0 | −184.9 | 18.90 |
| MLLT6 DRX059637 | 293 Kidney | 478 / 18550 (2.6%) | 688 / 185500 (0.4%) | −186.9 | −184.8 | 6.95 |
| JADE3 DRX234809 | 293 Kidney | 1162 / 18550 (6.3%) | 4032 / 185500 (2.2%) | −185.9 | −183.9 | 2.88 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 157 / 18550 (0.8%) | 8640 / 185500 (4.7%) | −185.7 | −183.6 | 0.18 |
| EP300 ERX626821 | U-937 Blood | 1379 / 18550 (7.4%) | 5338 / 185500 (2.9%) | −185.6 | −183.5 | 2.58 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 349 / 18550 (1.9%) | 12188 / 185500 (6.6%) | −185.4 | −183.3 | 0.29 |
| NR3C1 SRX10977372 | A549 Lung | 192 / 18550 (1.0%) | 9331 / 185500 (5.0%) | −185.3 | −183.2 | 0.21 |
| TCF21 DRX190655 | HCF Cardiovascular | 652 / 18550 (3.5%) | 17015 / 185500 (9.2%) | −185.1 | −183.0 | 0.38 |
| ESR1 SRX330067 | MCF-7 Breast | 339 / 18550 (1.8%) | 11999 / 185500 (6.5%) | −184.9 | −182.8 | 0.28 |
| FOXA1 SRX1787653 | MCF-7 Breast | 310 / 18550 (1.7%) | 11488 / 185500 (6.2%) | −184.7 | −182.6 | 0.27 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 497 / 18550 (2.7%) | 14598 / 185500 (7.9%) | −184.5 | −182.5 | 0.34 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 911 / 18550 (4.9%) | 2658 / 185500 (1.4%) | −184.5 | −182.4 | 3.43 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 355 / 18550 (1.9%) | 12257 / 185500 (6.6%) | −184.3 | −182.3 | 0.29 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 360 / 18550 (1.9%) | 12342 / 185500 (6.7%) | −184.3 | −182.3 | 0.29 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 496 / 18550 (2.7%) | 14573 / 185500 (7.9%) | −184.3 | −182.2 | 0.34 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 344 / 18550 (1.9%) | 12062 / 185500 (6.5%) | −184.2 | −182.1 | 0.29 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 300 / 18550 (1.6%) | 11285 / 185500 (6.1%) | −183.7 | −181.7 | 0.27 |
| NFIC SRX190336 | SK-N-SH Neural | 544 / 18550 (2.9%) | 15310 / 185500 (8.3%) | −183.7 | −181.6 | 0.36 |
| NR3C1 SRX10977373 | A549 Lung | 180 / 18550 (1.0%) | 9043 / 185500 (4.9%) | −183.6 | −181.6 | 0.20 |
| FOS SRX3322637 | MCF-7 Breast | 180 / 18550 (1.0%) | 9026 / 185500 (4.9%) | −183.0 | −181.0 | 0.20 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 601 / 18550 (3.2%) | 16164 / 185500 (8.7%) | −183.0 | −180.9 | 0.37 |
| STAT1 SRX23678708 | K-562 Blood | 1691 / 18550 (9.1%) | 7400 / 185500 (4.0%) | −182.4 | −180.4 | 2.29 |
| EP300 SRX10976215 | A549 Lung | 339 / 18550 (1.8%) | 11919 / 185500 (6.4%) | −182.3 | −180.3 | 0.28 |
| ESR1 SRX2881002 | MCF-7 Breast | 357 / 18550 (1.9%) | 12222 / 185500 (6.6%) | −182.3 | −180.2 | 0.29 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 759 / 18550 (4.1%) | 18498 / 185500 (10.0%) | −182.2 | −180.1 | 0.41 |
| EP300 SRX176885 | MCF-7 Breast | 182 / 18550 (1.0%) | 9042 / 185500 (4.9%) | −182.2 | −180.1 | 0.20 |
| ESR1 SRX2943591 | MCF-7 Breast | 258 / 18550 (1.4%) | 10475 / 185500 (5.6%) | −182.0 | −180.0 | 0.25 |
| ARID1A SRX5679787 | 12Z Others | 120 / 18550 (0.6%) | 7756 / 185500 (4.2%) | −182.0 | −179.9 | 0.15 |
| RELA SRX7055007 | HAEC Cardiovascular | 721 / 18550 (3.9%) | 17913 / 185500 (9.7%) | −181.6 | −179.5 | 0.40 |
| ARID1A SRX5679788 | 12Z Others | 133 / 18550 (0.7%) | 8017 / 185500 (4.3%) | −181.3 | −179.3 | 0.17 |
| FOXA1 SRX3923514 | MCF-7 Breast | 401 / 18550 (2.2%) | 12928 / 185500 (7.0%) | −181.2 | −179.2 | 0.31 |
| SMAD3 SRX366168 | NCI-H441 Lung | 323 / 18550 (1.7%) | 11605 / 185500 (6.3%) | −181.2 | −179.2 | 0.28 |
| FOXA1 SRX1161174 | MCF-7 Breast | 409 / 18550 (2.2%) | 13031 / 185500 (7.0%) | −180.4 | −178.3 | 0.31 |
| JUNB SRX2443774 | A549 Lung | 134 / 18550 (0.7%) | 8010 / 185500 (4.3%) | −180.4 | −178.3 | 0.17 |
| AGO2 SRX6783958 | Hep G2 Liver | 1287 / 18550 (6.9%) | 4860 / 185500 (2.6%) | −180.3 | −178.2 | 2.65 |
| ESR1 SRX330070 | MCF-7 Breast | 178 / 18550 (1.0%) | 8905 / 185500 (4.8%) | −180.1 | −178.1 | 0.20 |
| HMG20A SRX2630163 | Hep G2 Liver | 195 / 18550 (1.1%) | 9230 / 185500 (5.0%) | −179.9 | −177.8 | 0.21 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 321 / 18550 (1.7%) | 11522 / 185500 (6.2%) | −179.7 | −177.7 | 0.28 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 427 / 18550 (2.3%) | 13302 / 185500 (7.2%) | −179.6 | −177.6 | 0.32 |
| TEAD1 SRX3401272 | MCF-7 Breast | 287 / 18550 (1.5%) | 10914 / 185500 (5.9%) | −179.2 | −177.2 | 0.26 |
| FOXA1 SRX11222441 | MCF-7 Breast | 296 / 18550 (1.6%) | 11069 / 185500 (6.0%) | −179.2 | −177.2 | 0.27 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 153 / 18550 (0.8%) | 8364 / 185500 (4.5%) | −178.9 | −176.9 | 0.18 |
| ARID1A SRX5089379 | MCF-7 Breast | 387 / 18550 (2.1%) | 12617 / 185500 (6.8%) | −178.9 | −176.8 | 0.31 |
| ESR1 SRX330069 | MCF-7 Breast | 222 / 18550 (1.2%) | 9711 / 185500 (5.2%) | −178.8 | −176.8 | 0.23 |
| CEBPB SRX150598 | IMR-90 Lung | 811 / 18550 (4.4%) | 19107 / 185500 (10.3%) | −178.4 | −176.4 | 0.42 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 429 / 18550 (2.3%) | 13285 / 185500 (7.2%) | −178.1 | −176.1 | 0.32 |
| FOXA2 SRX100448 | Hep G2 Liver | 435 / 18550 (2.3%) | 13356 / 185500 (7.2%) | −177.3 | −175.3 | 0.33 |
| EP300 SRX190219 | SK-N-SH Neural | 377 / 18550 (2.0%) | 12393 / 185500 (6.7%) | −177.1 | −175.1 | 0.30 |
| CEBPA SRX2630241 | Hep G2 Liver | 485 / 18550 (2.6%) | 14143 / 185500 (7.6%) | −176.9 | −174.9 | 0.34 |
| FOXA1 SRX11222442 | MCF-7 Breast | 254 / 18550 (1.4%) | 10246 / 185500 (5.5%) | −176.9 | −174.9 | 0.25 |
| CEBPB SRX2194250 | SUM 159PT Breast | 476 / 18550 (2.6%) | 13994 / 185500 (7.5%) | −176.7 | −174.7 | 0.34 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 376 / 18550 (2.0%) | 12360 / 185500 (6.7%) | −176.6 | −174.6 | 0.30 |
| PROX1 SRX3230397 | Hep G2 Liver | 267 / 18550 (1.4%) | 10465 / 185500 (5.6%) | −176.4 | −174.4 | 0.26 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 818 / 18550 (4.4%) | 2267 / 185500 (1.2%) | −176.2 | −174.2 | 3.61 |
| EP300 SRX10976625 | A549 Lung | 204 / 18550 (1.1%) | 9291 / 185500 (5.0%) | −176.1 | −174.1 | 0.22 |
| ESR1 SRX371477 | MCF-7 Breast | 188 / 18550 (1.0%) | 8970 / 185500 (4.8%) | −175.6 | −173.6 | 0.21 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 230 / 18550 (1.2%) | 9764 / 185500 (5.3%) | −175.6 | −173.6 | 0.24 |
| FOXA1 SRX11222437 | MCF-7 Breast | 280 / 18550 (1.5%) | 10670 / 185500 (5.8%) | −175.5 | −173.5 | 0.26 |
| FOXA1 SRX100506 | Hep G2 Liver | 536 / 18550 (2.9%) | 14893 / 185500 (8.0%) | −175.4 | −173.4 | 0.36 |
| FOXA1 SRX13814018 | 5637 Others | 236 / 18550 (1.3%) | 9856 / 185500 (5.3%) | −175.0 | −173.0 | 0.24 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 477 / 18550 (2.6%) | 13943 / 185500 (7.5%) | −174.7 | −172.8 | 0.34 |
| JUN SRX2355073 | HAEC Cardiovascular | 501 / 18550 (2.7%) | 14311 / 185500 (7.7%) | −174.4 | −172.4 | 0.35 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 428 / 18550 (2.3%) | 13129 / 185500 (7.1%) | −174.1 | −172.1 | 0.33 |
| RNF2 SRX18954719 | SCC-25 Others | 544 / 18550 (2.9%) | 14966 / 185500 (8.1%) | −174.0 | −172.0 | 0.36 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 237 / 18550 (1.3%) | 9837 / 185500 (5.3%) | −173.7 | −171.7 | 0.24 |
| Epitope tags SRX2745846 | MCF 10A Breast | 248 / 18550 (1.3%) | 10033 / 185500 (5.4%) | −173.6 | −171.6 | 0.25 |
| NR3C1 SRX2609667 | HASM2 Lung | 384 / 18550 (2.1%) | 12364 / 185500 (6.7%) | −172.7 | −170.7 | 0.31 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 452 / 18550 (2.4%) | 13474 / 185500 (7.3%) | −172.7 | −170.7 | 0.34 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 144 / 18550 (0.8%) | 8004 / 185500 (4.3%) | −172.7 | −170.7 | 0.18 |
| FOXA1 SRX190282 | A549 Lung | 266 / 18550 (1.4%) | 10331 / 185500 (5.6%) | −172.6 | −170.6 | 0.26 |
| PGR SRX1012655 | MCF-7 Breast | 247 / 18550 (1.3%) | 9970 / 185500 (5.4%) | −172.1 | −170.1 | 0.25 |
| ESR1 SRX20282971 | MCF-7 Breast | 393 / 18550 (2.1%) | 12492 / 185500 (6.7%) | −172.1 | −170.1 | 0.31 |
| ESR1 SRX10365532 | MCF-7 Breast | 210 / 18550 (1.1%) | 9280 / 185500 (5.0%) | −171.9 | −169.9 | 0.23 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 484 / 18550 (2.6%) | 13951 / 185500 (7.5%) | −171.9 | −169.9 | 0.35 |
| CDK9 SRX7366781 | MCF-7 Breast | 267 / 18550 (1.4%) | 141 / 185500 (0.1%) | −171.7 | −169.7 | 18.94 |
| ESR1 SRX371475 | BT-474 Breast | 192 / 18550 (1.0%) | 8924 / 185500 (4.8%) | −171.6 | −169.6 | 0.22 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 840 / 18550 (4.5%) | 2433 / 185500 (1.3%) | −171.5 | −169.5 | 3.45 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 750 / 18550 (4.0%) | 17958 / 185500 (9.7%) | −171.4 | −169.4 | 0.42 |
| JUN SRX150358 | HUVEC Cardiovascular | 242 / 18550 (1.3%) | 9854 / 185500 (5.3%) | −171.3 | −169.3 | 0.25 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 377 / 18550 (2.0%) | 12184 / 185500 (6.6%) | −170.8 | −168.8 | 0.31 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 324 / 18550 (1.7%) | 11286 / 185500 (6.1%) | −170.8 | −168.8 | 0.29 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 464 / 18550 (2.5%) | 13597 / 185500 (7.3%) | −170.7 | −168.7 | 0.34 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 905 / 18550 (4.9%) | 20138 / 185500 (10.9%) | −170.6 | −168.6 | 0.45 |
| ESR1 SRX20282953 | MCF-7 Breast | 321 / 18550 (1.7%) | 11232 / 185500 (6.1%) | −170.6 | −168.6 | 0.29 |
| RELA SRX7054657 | HAEC Cardiovascular | 450 / 18550 (2.4%) | 13364 / 185500 (7.2%) | −170.5 | −168.6 | 0.34 |
| NR3C1 SRX18884271 | A549 Lung | 193 / 18550 (1.0%) | 8913 / 185500 (4.8%) | −170.5 | −168.6 | 0.22 |
| TLE3 SRX4815192 | MCF-7 Breast | 370 / 18550 (2.0%) | 12045 / 185500 (6.5%) | −170.1 | −168.1 | 0.31 |
| ESR1 SRX1469949 | MCF-7 Breast | 214 / 18550 (1.2%) | 9301 / 185500 (5.0%) | −170.0 | −168.1 | 0.23 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 497 / 18550 (2.7%) | 14093 / 185500 (7.6%) | −170.0 | −168.0 | 0.35 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 288 / 18550 (1.6%) | 10638 / 185500 (5.7%) | −170.0 | −168.0 | 0.27 |
| GFP SRX6949256 | HeLa Uterus | 441 / 18550 (2.4%) | 13192 / 185500 (7.1%) | −169.6 | −167.7 | 0.33 |
| NR2F2 SRX190293 | MCF-7 Breast | 431 / 18550 (2.3%) | 13028 / 185500 (7.0%) | −169.6 | −167.7 | 0.33 |
| FOXA1 SRX5323843 | MCF-7 Breast | 196 / 18550 (1.1%) | 8943 / 185500 (4.8%) | −169.5 | −167.5 | 0.22 |
| SMARCA4 SRX5982340 | A549 Lung | 139 / 18550 (0.7%) | 7806 / 185500 (4.2%) | −169.5 | −167.5 | 0.18 |
| RELA SRX7054617 | HAEC Cardiovascular | 486 / 18550 (2.6%) | 13899 / 185500 (7.5%) | −169.4 | −167.5 | 0.35 |
| AR SRX9469988 | LAPC-4 Prostate | 553 / 18550 (3.0%) | 14940 / 185500 (8.1%) | −169.4 | −167.5 | 0.37 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 264 / 18550 (1.4%) | 10187 / 185500 (5.5%) | −169.2 | −167.2 | 0.26 |
| FOXA1 SRX5203303 | MCF-7 Breast | 118 / 18550 (0.6%) | 7348 / 185500 (4.0%) | −169.0 | −167.0 | 0.16 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 731 / 18550 (3.9%) | 17581 / 185500 (9.5%) | −168.8 | −166.8 | 0.42 |
| ZEB1 SRX13298925 | MCF-7 Breast | 242 / 18550 (1.3%) | 9769 / 185500 (5.3%) | −168.4 | −166.5 | 0.25 |
| NR3C1 SRX17639413 | A549 Lung | 265 / 18550 (1.4%) | 10180 / 185500 (5.5%) | −168.4 | −166.4 | 0.26 |
| FOXA1 SRX100477 | Hep G2 Liver | 466 / 18550 (2.5%) | 13527 / 185500 (7.3%) | −167.9 | −165.9 | 0.34 |
| NR3C1 SRX19024866 | MCF-7 Breast | 125 / 18550 (0.7%) | 7468 / 185500 (4.0%) | −167.9 | −165.9 | 0.17 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 651 / 18550 (3.5%) | 1534 / 185500 (0.8%) | −167.7 | −165.8 | 4.24 |
| FOXA1 SRX1787651 | MCF-7 Breast | 225 / 18550 (1.2%) | 9434 / 185500 (5.1%) | −167.7 | −165.7 | 0.24 |
| FOXA1 SRX028634 | MCF-7 Breast | 192 / 18550 (1.0%) | 8802 / 185500 (4.7%) | −167.4 | −165.5 | 0.22 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 194 / 18550 (1.0%) | 8840 / 185500 (4.8%) | −167.4 | −165.4 | 0.22 |
| FOSL1 SRX17608312 | T24 Others | 137 / 18550 (0.7%) | 7701 / 185500 (4.2%) | −167.2 | −165.3 | 0.18 |
| FOXA1 SRX1787652 | MCF-7 Breast | 241 / 18550 (1.3%) | 9711 / 185500 (5.2%) | −167.2 | −165.2 | 0.25 |
| ARID1A SRX5089385 | MCF-7 Breast | 299 / 18550 (1.6%) | 10741 / 185500 (5.8%) | −167.1 | −165.2 | 0.28 |
| ESR1 SRX3110725 | MCF-7 Breast | 366 / 18550 (2.0%) | 11865 / 185500 (6.4%) | −166.7 | −164.7 | 0.31 |
| ESR1 SRX371474 | BT-474 Breast | 175 / 18550 (0.9%) | 8452 / 185500 (4.6%) | −166.6 | −164.7 | 0.21 |
| ESR1 SRX5323873 | MCF-7 Breast | 503 / 18550 (2.7%) | 14069 / 185500 (7.6%) | −166.6 | −164.7 | 0.36 |
| ESR1 SRX20282938 | MCF-7 Breast | 322 / 18550 (1.7%) | 11118 / 185500 (6.0%) | −166.5 | −164.6 | 0.29 |
| ARID5B SRX3230377 | Hep G2 Liver | 1038 / 18550 (5.6%) | 21818 / 185500 (11.8%) | −166.5 | −164.6 | 0.48 |
| ESR1 SRX1469951 | MCF-7 Breast | 193 / 18550 (1.0%) | 8791 / 185500 (4.7%) | −166.4 | −164.5 | 0.22 |
| GFP SRX5417098 | HeLa Uterus | 478 / 18550 (2.6%) | 13661 / 185500 (7.4%) | −166.2 | −164.3 | 0.35 |
| ESR1 SRX8537722 | MCF-7 Breast | 380 / 18550 (2.0%) | 12076 / 185500 (6.5%) | −166.1 | −164.2 | 0.31 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 694 / 18550 (3.7%) | 16930 / 185500 (9.1%) | −166.0 | −164.1 | 0.41 |
| ESR1 SRX2943589 | MCF-7 Breast | 196 / 18550 (1.1%) | 8837 / 185500 (4.8%) | −166.0 | −164.1 | 0.22 |
| NR3C1 SRX8520802 | HCC1187 Breast | 297 / 18550 (1.6%) | 10657 / 185500 (5.7%) | −165.6 | −163.7 | 0.28 |
| ESR1 SRX3123829 | MCF-7 Breast | 225 / 18550 (1.2%) | 9369 / 185500 (5.1%) | −165.6 | −163.7 | 0.24 |
| TEAD1 SRX716558 | SF268 Neural | 191 / 18550 (1.0%) | 8723 / 185500 (4.7%) | −165.4 | −163.4 | 0.22 |
| IRF3 SRX11453861 | Hep G2 Liver | 247 / 18550 (1.3%) | 116 / 185500 (0.1%) | −165.2 | −163.3 | 21.29 |
| ESR1 SRX20282946 | MCF-7 Breast | 238 / 18550 (1.3%) | 9594 / 185500 (5.2%) | −165.1 | −163.2 | 0.25 |
| ESR1 SRX10365533 | MCF-7 Breast | 186 / 18550 (1.0%) | 8612 / 185500 (4.6%) | −164.9 | −163.0 | 0.22 |
| FOXL2 SRX6957477 | KGN Gonad | 422 / 18550 (2.3%) | 12721 / 185500 (6.9%) | −164.9 | −163.0 | 0.33 |
| ESR1 SRX5323871 | MCF-7 Breast | 449 / 18550 (2.4%) | 13146 / 185500 (7.1%) | −164.7 | −162.8 | 0.34 |
| ESR1 SRX10365558 | MCF-7 Breast | 272 / 18550 (1.5%) | 10182 / 185500 (5.5%) | −164.5 | −162.6 | 0.27 |
| STAT3 SRX4192888 | MCF 10A Breast | 186 / 18550 (1.0%) | 8596 / 185500 (4.6%) | −164.3 | −162.4 | 0.22 |
| SMC1A SRX1013334 | HuCCT1 Liver | 1200 / 18550 (6.5%) | 23879 / 185500 (12.9%) | −163.6 | −161.7 | 0.50 |
| SOX13 SRX2636248 | Hep G2 Liver | 575 / 18550 (3.1%) | 15054 / 185500 (8.1%) | −163.2 | −161.3 | 0.38 |
| GATAD2A SRX2636506 | Hep G2 Liver | 537 / 18550 (2.9%) | 14461 / 185500 (7.8%) | −163.0 | −161.0 | 0.37 |
| CEBPB SRX2194249 | SUM 159PT Breast | 402 / 18550 (2.2%) | 12327 / 185500 (6.6%) | −162.8 | −160.9 | 0.33 |
| FOXA1 SRX3931043 | MCF-7 Breast | 434 / 18550 (2.3%) | 12836 / 185500 (6.9%) | −162.6 | −160.7 | 0.34 |
| ESR1 SRX1012629 | MCF-7 Breast | 250 / 18550 (1.3%) | 9733 / 185500 (5.2%) | −162.6 | −160.7 | 0.26 |
| RELA SRX7054663 | HAEC Cardiovascular | 344 / 18550 (1.9%) | 11362 / 185500 (6.1%) | −162.6 | −160.7 | 0.30 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 343 / 18550 (1.8%) | 11339 / 185500 (6.1%) | −162.5 | −160.6 | 0.30 |
| RAD21 SRX150650 | HeLa Uterus | 564 / 18550 (3.0%) | 14849 / 185500 (8.0%) | −162.3 | −160.4 | 0.38 |
| MEN1 SRX11712604 | K-562 Blood | 1514 / 18550 (8.2%) | 6633 / 185500 (3.6%) | −162.1 | −160.2 | 2.28 |
| SETD1A SRX23734379 | MOLM-13 Blood | 1320 / 18550 (7.1%) | 5381 / 185500 (2.9%) | −161.7 | −159.8 | 2.45 |
| Epitope tags SRX15939724 | RD Muscle | 361 / 18550 (1.9%) | 11611 / 185500 (6.3%) | −161.6 | −159.7 | 0.31 |
| EP300 SRX1012648 | MCF-7 Breast | 190 / 18550 (1.0%) | 8586 / 185500 (4.6%) | −161.5 | −159.6 | 0.22 |
| KAT7 DRX300414 | 293 Kidney | 688 / 18550 (3.7%) | 1769 / 185500 (1.0%) | −161.4 | −159.5 | 3.89 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 393 / 18550 (2.1%) | 12133 / 185500 (6.5%) | −161.4 | −159.5 | 0.32 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1626 / 18550 (8.8%) | 7400 / 185500 (4.0%) | −161.4 | −159.5 | 2.20 |
| NR3C1 SRX18884260 | A549 Lung | 225 / 18550 (1.2%) | 9235 / 185500 (5.0%) | −161.3 | −159.4 | 0.24 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 592 / 18550 (3.2%) | 15231 / 185500 (8.2%) | −161.1 | −159.2 | 0.39 |
| FOXA2 SRX3230382 | Hep G2 Liver | 583 / 18550 (3.1%) | 15080 / 185500 (8.1%) | −160.7 | −158.8 | 0.39 |
| FOXA1 SRX1787655 | MCF-7 Breast | 203 / 18550 (1.1%) | 8803 / 185500 (4.7%) | −160.5 | −158.7 | 0.23 |
| TP53 SRX396254 | Fibroblasts Others | 922 / 18550 (5.0%) | 3015 / 185500 (1.6%) | −160.2 | −158.3 | 3.06 |
| SMARCA4 SRX5982364 | A549 Lung | 113 / 18550 (0.6%) | 6985 / 185500 (3.8%) | −159.7 | −157.8 | 0.16 |
| ESR1 SRX11120903 | MCF-7 Breast | 360 / 18550 (1.9%) | 11527 / 185500 (6.2%) | −159.5 | −157.6 | 0.31 |
| FOXA1 SRX3931055 | MCF-7 Breast | 365 / 18550 (2.0%) | 11595 / 185500 (6.3%) | −159.1 | −157.3 | 0.31 |
| CREBBP SRX7214025 | Keratinocytes Epidermis | 247 / 18550 (1.3%) | 9563 / 185500 (5.2%) | −159.0 | −157.1 | 0.26 |
| YAP1 SRX10119363 | MCF 10A Breast | 167 / 18550 (0.9%) | 8064 / 185500 (4.3%) | −158.9 | −157.0 | 0.21 |
| SMARCA2 SRX5982361 | A549 Lung | 117 / 18550 (0.6%) | 7039 / 185500 (3.8%) | −158.6 | −156.7 | 0.17 |
| FOXA1 SRX5203307 | MCF-7 Breast | 110 / 18550 (0.6%) | 6882 / 185500 (3.7%) | −158.5 | −156.6 | 0.16 |
| Epitope tags SRX5877912 | U2OS Bone | 2366 / 18550 (12.8%) | 38264 / 185500 (20.6%) | −158.2 | −156.3 | 0.62 |
| RELA SRX7054618 | HAEC Cardiovascular | 416 / 18550 (2.2%) | 12385 / 185500 (6.7%) | −158.0 | −156.1 | 0.34 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 142 / 18550 (0.8%) | 7536 / 185500 (4.1%) | −157.9 | −156.0 | 0.19 |
| STAT1 SRX23678707 | K-562 Blood | 1526 / 18550 (8.2%) | 6802 / 185500 (3.7%) | −157.7 | −155.8 | 2.24 |
| NR3C1 SRX10976922 | A549 Lung | 158 / 18550 (0.9%) | 7851 / 185500 (4.2%) | −157.7 | −155.8 | 0.20 |
| ARID1A SRX5089388 | MCF-7 Breast | 205 / 18550 (1.1%) | 8753 / 185500 (4.7%) | −157.7 | −155.8 | 0.23 |
| FOXA1 SRX3923516 | MCF-7 Breast | 309 / 18550 (1.7%) | 10601 / 185500 (5.7%) | −157.6 | −155.7 | 0.29 |
| KMT2D SRX15826241 | MDA-MB-231 Breast | 128 / 18550 (0.7%) | 7238 / 185500 (3.9%) | −157.4 | −155.5 | 0.18 |
| TP53 SRX19538271 | U2OS Bone | 607 / 18550 (3.3%) | 1421 / 185500 (0.8%) | −157.4 | −155.5 | 4.27 |
| FOXA1 SRX5203294 | MCF-7 Breast | 106 / 18550 (0.6%) | 6768 / 185500 (3.6%) | −157.3 | −155.5 | 0.16 |
| FOXA1 SRX3923517 | MCF-7 Breast | 303 / 18550 (1.6%) | 10488 / 185500 (5.7%) | −157.2 | −155.3 | 0.29 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1475 / 18550 (8.0%) | 27175 / 185500 (14.6%) | −156.9 | −155.0 | 0.54 |
| JUN SRX150421 | HeLa Uterus | 140 / 18550 (0.8%) | 7465 / 185500 (4.0%) | −156.7 | −154.9 | 0.19 |
| ESR1 SRX5534832 | MCF-7 Breast | 386 / 18550 (2.1%) | 11858 / 185500 (6.4%) | −156.7 | −154.8 | 0.33 |
| AR SRX1067068 | LHSAR Prostate | 517 / 18550 (2.8%) | 13924 / 185500 (7.5%) | −156.6 | −154.8 | 0.37 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1475 / 18550 (8.0%) | 27161 / 185500 (14.6%) | −156.6 | −154.7 | 0.54 |
| JUN SRX699737 | HCASMC Cardiovascular | 273 / 18550 (1.5%) | 9943 / 185500 (5.4%) | −156.4 | −154.6 | 0.27 |
| NR3C1 SRX2609668 | HASM2 Lung | 318 / 18550 (1.7%) | 10718 / 185500 (5.8%) | −156.4 | −154.6 | 0.30 |
| TFAP2C SRX018833 | MCF-7 Breast | 389 / 18550 (2.1%) | 11897 / 185500 (6.4%) | −156.4 | −154.5 | 0.33 |
| STAT3 SRX8520800 | SUM 159PT Breast | 249 / 18550 (1.3%) | 9516 / 185500 (5.1%) | −156.4 | −154.5 | 0.26 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 200 / 18550 (1.1%) | 8621 / 185500 (4.6%) | −156.3 | −154.4 | 0.23 |
| ATF3 SRX1384025 | HCT 116 Digestive tract | 249 / 18550 (1.3%) | 9514 / 185500 (5.1%) | −156.2 | −154.3 | 0.26 |
| ESR1 SRX1012632 | MCF-7 Breast | 205 / 18550 (1.1%) | 8708 / 185500 (4.7%) | −156.2 | −154.3 | 0.24 |
| ARID5B SRX10475139 | Hep G2 Liver | 468 / 18550 (2.5%) | 13138 / 185500 (7.1%) | −155.9 | −154.0 | 0.36 |
| ESR1 SRX5323872 | MCF-7 Breast | 426 / 18550 (2.3%) | 12472 / 185500 (6.7%) | −155.9 | −154.0 | 0.34 |
| FOSL2 SRX10475405 | A549 Lung | 155 / 18550 (0.8%) | 7741 / 185500 (4.2%) | −155.9 | −154.0 | 0.20 |
| GRHL2 SRX268451 | Tracheal epithelial cells Lung | 270 / 18550 (1.5%) | 9869 / 185500 (5.3%) | −155.7 | −153.9 | 0.27 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 580 / 18550 (3.1%) | 14848 / 185500 (8.0%) | −155.7 | −153.8 | 0.39 |
| ESR1 SRX330068 | MCF-7 Breast | 192 / 18550 (1.0%) | 8449 / 185500 (4.6%) | −155.6 | −153.7 | 0.23 |
| MITF SRX7368256 | Hermes 3C Epidermis | 850 / 18550 (4.6%) | 18758 / 185500 (10.1%) | −155.5 | −153.6 | 0.45 |
| ESR1 SRX2513517 | MCF-7 Breast | 285 / 18550 (1.5%) | 10115 / 185500 (5.5%) | −155.2 | −153.3 | 0.28 |
| TLE3 SRX4815193 | SUM 149PT Breast | 431 / 18550 (2.3%) | 12528 / 185500 (6.8%) | −155.2 | −153.3 | 0.34 |
| ZEB1 SRX13298924 | MCF-7 Breast | 197 / 18550 (1.1%) | 8529 / 185500 (4.6%) | −155.2 | −153.3 | 0.23 |
| ESR1 SRX1531796 | MCF-7 Breast | 219 / 18550 (1.2%) | 8937 / 185500 (4.8%) | −155.1 | −153.3 | 0.25 |
| FOXA1 SRX15430999 | T-47D Breast | 484 / 18550 (2.6%) | 13361 / 185500 (7.2%) | −155.1 | −153.3 | 0.36 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 286 / 18550 (1.5%) | 10126 / 185500 (5.5%) | −155.0 | −153.2 | 0.28 |
| BRD4 SRX327752 | U-87 MG Neural | 774 / 18550 (4.2%) | 17656 / 185500 (9.5%) | −154.9 | −153.1 | 0.44 |
| FOXA1 SRX6441748 | CFPAC-1 Pancreas | 133 / 18550 (0.7%) | 7268 / 185500 (3.9%) | −154.8 | −153.0 | 0.18 |
| FOXA1 SRX1447317 | MCF-7 Breast | 281 / 18550 (1.5%) | 10030 / 185500 (5.4%) | −154.8 | −153.0 | 0.28 |
| RELA SRX7054609 | HAEC Cardiovascular | 345 / 18550 (1.9%) | 11114 / 185500 (6.0%) | −154.7 | −152.9 | 0.31 |
| ZEB1 SRX13298923 | MCF-7 Breast | 172 / 18550 (0.9%) | 8040 / 185500 (4.3%) | −154.7 | −152.8 | 0.21 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 311 / 18550 (1.7%) | 10543 / 185500 (5.7%) | −154.7 | −152.8 | 0.29 |
| ARID1A SRX5089382 | MCF-7 Breast | 301 / 18550 (1.6%) | 10367 / 185500 (5.6%) | −154.6 | −152.7 | 0.29 |
| FOXA1 SRX3931054 | MCF-7 Breast | 411 / 18550 (2.2%) | 12187 / 185500 (6.6%) | −154.5 | −152.7 | 0.34 |
| SMARCA4 SRX5982341 | A549 Lung | 113 / 18550 (0.6%) | 6835 / 185500 (3.7%) | −154.5 | −152.6 | 0.17 |
| HOXC5 SRX2731653 | PC-3 Prostate | 336 / 18550 (1.8%) | 10948 / 185500 (5.9%) | −154.2 | −152.4 | 0.31 |
| EP300 SRX717859 | HeLa Uterus | 218 / 18550 (1.2%) | 8887 / 185500 (4.8%) | −154.2 | −152.3 | 0.25 |
| FOXA1 SRX028635 | MCF-7 Breast | 217 / 18550 (1.2%) | 8865 / 185500 (4.8%) | −153.9 | −152.1 | 0.24 |
| CEBPB SRX7807103 | Adipocytes Adipocyte | 392 / 18550 (2.1%) | 11855 / 185500 (6.4%) | −153.7 | −151.9 | 0.33 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 323 / 18550 (1.7%) | 10707 / 185500 (5.8%) | −153.4 | −151.6 | 0.30 |
| CEBPB SRX7807101 | Unclassified Unclassified | 310 / 18550 (1.7%) | 10473 / 185500 (5.6%) | −153.1 | −151.3 | 0.30 |
| ESR1 SRX1012633 | MCF-7 Breast | 216 / 18550 (1.2%) | 8818 / 185500 (4.8%) | −153.1 | −151.3 | 0.24 |
| TEAD4 SRX10640863 | SK-MEL-147 Epidermis | 594 / 18550 (3.2%) | 14961 / 185500 (8.1%) | −153.1 | −151.2 | 0.40 |
| NR3C1 SRX10976392 | A549 Lung | 180 / 18550 (1.0%) | 8142 / 185500 (4.4%) | −153.0 | −151.2 | 0.22 |
| ESR1 SRX5323878 | MCF-7 Breast | 434 / 18550 (2.3%) | 12501 / 185500 (6.7%) | −153.0 | −151.2 | 0.35 |
| EP300 SRX1012644 | MCF-7 Breast | 189 / 18550 (1.0%) | 8306 / 185500 (4.5%) | −152.8 | −151.0 | 0.23 |
| TFAP2C SRX128099 | MCF-7 Breast | 396 / 18550 (2.1%) | 11886 / 185500 (6.4%) | −152.7 | −150.9 | 0.33 |
| EP300 SRX176883 | MCF-7 Breast | 194 / 18550 (1.0%) | 8397 / 185500 (4.5%) | −152.7 | −150.9 | 0.23 |
| ESR1 SRX8537723 | MCF-7 Breast | 347 / 18550 (1.9%) | 11082 / 185500 (6.0%) | −152.7 | −150.9 | 0.31 |
| SSRP1 SRX3436567 | HT-1080 Bone | 409 / 18550 (2.2%) | 630 / 185500 (0.3%) | −152.3 | −150.5 | 6.49 |
| FOSL2 SRX10475315 | Hep G2 Liver | 474 / 18550 (2.6%) | 13105 / 185500 (7.1%) | −152.3 | −150.5 | 0.36 |
| ESR1 SRX20282959 | MCF-7 Breast | 170 / 18550 (0.9%) | 7930 / 185500 (4.3%) | −152.3 | −150.5 | 0.21 |
| NR3C1 SRX10977364 | A549 Lung | 175 / 18550 (0.9%) | 8024 / 185500 (4.3%) | −152.3 | −150.4 | 0.22 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1152 / 18550 (6.2%) | 22742 / 185500 (12.3%) | −152.3 | −150.4 | 0.51 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 401 / 18550 (2.2%) | 11941 / 185500 (6.4%) | −152.0 | −150.2 | 0.34 |
| KMT2A SRX5732680 | MOLM-13 Blood | 1428 / 18550 (7.7%) | 6269 / 185500 (3.4%) | −151.8 | −150.0 | 2.28 |
| CEBPB SRX3584202 | Epididymis Gonad | 403 / 18550 (2.2%) | 11952 / 185500 (6.4%) | −151.5 | −149.6 | 0.34 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 693 / 18550 (3.7%) | 1898 / 185500 (1.0%) | −151.1 | −149.3 | 3.65 |
| DOT1L DRX411731 | 293 Kidney | 318 / 18550 (1.7%) | 334 / 185500 (0.2%) | −151.1 | −149.3 | 9.52 |
Showing first 500 of 20485 rows.